⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VTRS

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

16.50USD

-0.1100 (-0.66%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY16.2B15.4B14.7B14.3B14.8B15.0B
Q14.2B3.7B3.7B3.2B3.5B—
Q24.1B3.9B3.8B3.6B3.7B—
Q34.1B3.9B3.7B3.7B3.8B—
Q43.9B*3.8B*3.5B*3.7B*3.7B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY1.71.050-.530-3.002.512.67
Q1.330.190.090-2.55.150—
Q2.260.220-.270.000-.100—
Q3.290.270.080-.110.650—
Q4.830*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-.630*
-.430*
-.300*
.583
—